Regulating human stem cell research and therapy in low- and middle-income countries: Malaysian perspectives
Many “rising powers” such as India, China, Argentina, Singapore, and Brazil are investing in stem cell technology, joining the traditional leaders in the field, such as the UK, Germany, USA, and Japan. Malaysia is also entering this sector because of the potential medical and economic benefits that...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Published: |
Taylor & Francis
2018
|
| Subjects: |